| Financial Year |
March 31 2023 |
| Monetary Funds |
2,552,833,368.87 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
601,455,483.33 |
| Accounts Receivable |
45,718,465.20 |
| Advances to Suppliers |
9,239,489.19 |
| Other Receivables |
5,811,265.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
95,363,028.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,597,411.08 |
| Total Current Assets |
3,459,047,837.80 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
314,548,849.06 |
| Investment Properties |
-- |
| Fixed Assetes |
1,010,370,573.93 |
| Under-construction Projects |
305,908,981.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
485,565,648.33 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
158,192,928.98 |
| Deferred Income Tax Assets |
15,353,227.07 |
| Other Non-Current Assets |
156,721,659.60 |
| Sub-Total of Non-Current Assets |
3,164,759,679.88 |
| Total Assets |
6,623,807,517.68 |
| Short-Term Loans |
174,966,537.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
112,918,729.92 |
| Accounts Payable |
203,794,593.79 |
| Accounts Received In Advance |
25,600.00 |
| Employee Compensation Payable |
25,843,619.89 |
| Taxes Payable |
98,012,788.12 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,222,802.77 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,262,184.14 |
| Other Current Liabilities |
23,472,503.04 |
| Sub-Total of Current Liabilities |
715,167,153.06 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
89,726,710.43 |
| Deferred Income Tax Liabilities |
19,614,007.85 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
214,699,155.83 |
| Total Liabilities |
929,866,308.89 |
| Paid-In Capital(Or Share Stock) |
401,000,000.00 |
| Capital Surplus |
1,024,972,067.34 |
| Surplus Reserve |
224,804,867.77 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,945,878,700.39 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,693,941,208.79 |
| Owner's Equity（Stockholder's Equity） |
5,693,941,208.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,623,807,517.68 |
